Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications
PTPN6/SHP-1 in autoimmune disease: immune tolerance, regulatory mechanisms, and therapeutic targeting.
Journal: Frontiers in immunology
Published: March 26, 2026
Hiding in plain sight: Pathogenic insights from nonlesional skin in gliptin-associated bullous pemphigoid.
Journal: The Journal of investigative dermatology
Published: February 25, 2026
Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunities.
Journal: Frontiers in medicine
Published: February 09, 2026
The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response.
Journal: Experimental dermatology
Published: February 02, 2026
CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target.
Journal: Experimental dermatology
Published: January 31, 2026
Antigen-presenting cell phenotype of skin-infiltrating eosinophils in bullous pemphigoid patients.
Journal: European journal of dermatology : EJD
Published: January 29, 2026
Review of Low-Dose Naltrexone for Hailey-Hailey Disease Suggests Lack of Benefit in Dose Escalation.
Review of Low-Dose Naltrexone for Hailey-Hailey Disease Suggests Lack of Benefit in Dose Escalation.
Journal: International journal of dermatology
Published: January 16, 2026
Racial differences in comorbidities and mortality in US patients with bullous pemphigoid: A propensity matched cohort study.
Journal: Journal of the American Academy of Dermatology
Published: December 09, 2025
Two cases of treatment-resistant erythema nodosum responding favorably to infliximab in the absence of gastrointestinal disease.
Journal: JAAD case reports
Published: November 11, 2025
Last Updated: 09/26/2026